RICHMOND, VIRGINIA; July 31, 2018 – The Arcady Group, LLC, a consulting company that works to enhance patient and disease management by addressing the challenges of medication non-adherence, has been awarded a grant from the Bill & Melinda Gates Foundation to continue Arcady’s activities to improve TB medication adherence and TB treatment outcomes. Under this most recent grant, the third from the Foundation, Arcady will be focused primarily on the further scaled deployment and systematic evaluation of patient-centric, highly affordable, highly scalable medication adherence monitoring technologies for use with TB patients in high burden regions worldwide.
Download attachment to continue reading press release.